ARTICLES BY THIS AUTHOR

• 6/1/2021

  JAMA editor resigns over fallout after racism podcast

• 6/1/2021

  Optimal level of oral corticosteroids for asthma as close to zero as possible, expert says

  The optimal level of oral corticosteroids (OCS) for asthma should be as close to zero as possible, according to one of Canada’s top asthma doctors.
• 6/1/2021

  Newer methods may boost gene therapy's use for more diseases

• 6/1/2021

  Disaster Pharmacy: Pharmacists are essential for emergency management

• 6/1/2021

  Rural Manitoba struggling with patients who believe COVID-19 is a hoax even as they die

• 5/31/2021

  A new eCortex is coming soon!

• 5/31/2021

  How technology can support your pharmacy’s future

• 5/31/2021

  5 key steps to securing your retirement in uncertain times

• 5/31/2021

  Mental health impact of COVID-19 outlasts physical illness: studies

• 5/31/2021

  Saskatchewan pharmacies meeting demand for Covid-19 vaccines

• 5/31/2021

  Vancouver sends drug decriminalization pitch to Health Canada for federal review

• 5/31/2021

  Biologic tezepelumab shows positive results in severe, uncontrolled asthma

  Tezepelumab is associated with reduced exacerbations, hospitalizations and ER visits in people with severe, uncontrolled asthma. It may also challenge the current step of biomarker assessment before initiating treatment with a biologic.